文献速递神经MR

海马特征综合表征作为阿尔茨海默病个体化脑标志物的深度学习研究

A comprehensive characterization of hippocampal feature ensemble serves as individualized brain signature for Alzheimer's disease: deep learning analysis in 3238 participants worldwide.
PubMed 文献 · Eur Radiol · 2023-03-09

基于全球四个独立数据库共3238名参与者的结构MRI,采用3D残差注意力网络整合海马灰质体积、分割概率和影像组学特征,对正常对照、轻度认知障碍和阿尔茨海默病进行分类。在ADNI队列中区分AD与NC的准确率达91.6%、AUC达0.95,外部验证准确率89.2%、AUC达0.93,且分类决策评分与临床指标显著相关并随AD纵向进展动态变化。

要点

  • 海马多层级特征(体积、分割概率、影像组学)联合优于单一特征,可提升AD与NC的区分能力。
  • 模型在外部数据库验证中保持较高泛化性,支持其作为个体化脑影像标志物的潜力。
  • 分类决策评分与临床指标相关且随AD进展动态变化,具有神经生物学基础。

核心结论

  • 海马灰质体积、分割概率和影像组学特征的综合表征可有效区分AD与NC,并作为个体化、可泛化且具生物学合理性的AD早期检测神经影像标志物。

研究设计与样本

  • 研究采用多中心回顾性设计,纳入四个独立数据库共3238名参与者的结构MRI数据,仅使用T1加权单模态图像。
  • 构建3D残差注意力网络(3DRA-Net)对NC、MCI和AD进行分类,并通过数据库间交叉验证评估泛化性。
  • 在阿尔茨海默病神经影像学倡议(ADNI)队列中,AD组282例、NC组603例用于内部数据库交叉验证性能评估。
  • 通过分类决策评分与临床指标关联分析及纵向轨迹分析,系统探究其神经生物学基础。

诊断标准与关键数值

  • 在ADNI队列内部数据库交叉验证中,综合海马特征区分AD(n=282)与NC(n=603)的准确率为91.6%,AUC为0.95。
  • 在外部验证中,区分AD与NC的准确率为89.2%,AUC为0.93。
  • 分类决策评分与临床指标显著相关(p < 0.05),并随AD纵向进展动态改变。

临床应用与阅片要点

  • 日常阅片时可关注海马灰质体积、分割概率及影像组学特征的综合性改变,而非仅依赖单一指标。
  • 该模型基于T1加权MRI单模态,便于在常规结构扫描中应用,但需注意其性能数据来自特定队列,实际应用中应结合临床背景综合判断。
  • 分类决策评分可作为个体化脑标志物候选,但当前尚未提供具体阈值或分级标准,不宜直接用于临床诊断决策。

局限性

  • 研究为回顾性多数据库分析,虽经外部验证,但未报告前瞻性临床验证结果。
  • 分类性能仅在AD与NC区分中报告,MCI分类的具体性能数值未在摘要中给出。
  • 模型依赖海马区域特征,对海马以外脑区改变及非AD痴呆的鉴别能力未涉及。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Hippocampal characterization is one of the most significant hallmarks of Alzheimer's disease (AD); rather, the single-level feature is insufficient. A comprehensive hippocampal characterization is pivotal for developing a well-performing biomarker for AD. To verify whether a comprehensive characterization of hippocampal features of gray matter volume, segmentation probability, and radiomics features could better distinguish AD from normal control (NC), and to investigate whether the classification decision score could serve as a robust and individualized brain signature.

METHODS: A total of 3238 participants' structural MRI from four independent databases were employed to conduct a 3D residual attention network (3DRA-Net) to classify NC, mild cognitive impairment (MCI), and AD. The generalization was validated under inter-database cross-validation. The neurobiological basis of the classification decision score as a neuroimaging biomarker was systematically investigated by association with clinical profiles, as well as longitudinal trajectory analysis to reveal AD progression. All image analyses were performed only upon the single modality of T1-weighted MRI.

RESULTS: Our study exhibited an outstanding performance (ACC = 91.6%, AUC = 0.95) of the comprehensive characterization of hippocampal features in distinguishing AD (n = 282) from NC (n = 603) in Alzheimer's Disease Neuroimaging Initiative cohort, and ACC = 89.2% and AUC = 0.93 under external validation. More importantly, the constructed score was significantly correlated with clinical profiles (p < 0.05), and dynamically altered over the AD longitudinal progression, provided compelling evidence of a solid neurobiological basis.

CONCLUSIONS: This systemic study highlights the potential of the comprehensive characterization of hippocampal features to provide an individualized, generalizable, and biologically plausible neuroimaging biomarker for early detection of AD.

KEY POINTS: • The comprehensive characterization of hippocampal features exhibited ACC = 91.6% (AUC = 0.95) in classifying AD from NC under intra-database cross-validation, and ACC = 89.2% (AUC = 0.93) in external validation. • The constructed classification score was significantly associated with clinical profiles, and dynamically altered over the AD longitudinal progression, which highlighted its potential of being an individualized, generalizable, and biologically plausible neuroimaging biomarker for early detection of AD.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang, Li, Zheng, et al. A comprehensive characterization of hippocampal feature ensemble serves as individualized brain signature for Alzheimer's disease: deep learning analysis in 3238 participants worldwide. Eur Radiol. 2023. PMID: 36892643. doi:10.1007/s00330-023-09519-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。